These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 1316628)

  • 1. Maturation of functional antibody affinity in animals immunised with synthetic foot-and-mouth disease virus.
    Mulcahy G; Reid E; Dimarchi RD; Gale C; Doel TR
    Res Vet Sci; 1992 Mar; 52(2):133-40. PubMed ID: 1316628
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isotype responses of infected, virus-vaccinated and peptide-vaccinated cattle to foot-and-mouth disease virus.
    Mulcahy G; Gale C; Robertson P; Iyisan S; DiMarchi RD; Doel TR
    Vaccine; 1990 Jun; 8(3):249-56. PubMed ID: 2163575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Versatility of the adenovirus-vectored foot-and-mouth disease vaccine platform across multiple foot-and-mouth disease virus serotypes and topotypes using a vaccine dose representative of the AdtA24 conditionally licensed vaccine.
    Barrera J; Brake DA; Schutta C; Ettyreddy D; Kamicker BJ; Rasmussen MV; Bravo de Rueda C; Zurita M; Pisano M; Hurtle W; Brough DE; Butman BT; Harper BG; Neilan JG
    Vaccine; 2018 Nov; 36(48):7345-7352. PubMed ID: 30327212
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Montanide ISA™ 201 adjuvanted FMD vaccine induces improved immune responses and protection in cattle.
    Dar P; Kalaivanan R; Sied N; Mamo B; Kishore S; Suryanarayana VV; Kondabattula G
    Vaccine; 2013 Jul; 31(33):3327-32. PubMed ID: 23735678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The biological relevance of virus neutralisation sites for virulence and vaccine protection in the guinea pig model of foot-and-mouth disease.
    Dunn CS; Samuel AR; Pullen LA; Anderson J
    Virology; 1998 Jul; 247(1):51-61. PubMed ID: 9683571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment using ELISA of the herd immunity levels induced in cattle by foot-and-mouth disease oil vaccines.
    Smitsaart EN; Zanelli M; Rivera I; Fondevila N; Compaired D; Maradei E; Bianchi T; O'Donnell V; Schudel AA
    Prev Vet Med; 1998 Jan; 33(1-4):283-96. PubMed ID: 9500182
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined vaccination of cattle against FMD and rabies.
    Palanisamy R; Ramanna BC; Ananda Rao K; Srinivasan VA
    Microbiologica; 1992 Jan; 15(1):45-9. PubMed ID: 1313530
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant human adenovirus-5 expressing capsid proteins of Indian vaccine strains of foot-and-mouth disease virus elicits effective antibody response in cattle.
    Sreenivasa BP; Mohapatra JK; Pauszek SJ; Koster M; Dhanya VC; Tamil Selvan RP; Hosamani M; Saravanan P; Basagoudanavar SH; de Los Santos T; Venkataramanan R; Rodriguez LL; Grubman MJ
    Vet Microbiol; 2017 May; 203():196-201. PubMed ID: 28619144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of ENABL® adjuvant to increase the potency of an adenovirus-vectored foot-and-mouth disease virus serotype A subunit vaccine.
    Barrera J; Schutta C; Pisano M; Grubman MJ; Brake DA; Miller T; Kamicker BJ; Olutunmbi F; Ettyreddy D; Brough DE; Butman BT; Neilan JG
    Vaccine; 2018 Feb; 36(8):1078-1084. PubMed ID: 29358056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between the anti-FMD virus antibody reaction as measured by different assays, and protection in vivo against challenge infection.
    McCullough KC; Bruckner L; Schaffner R; Fraefel W; Müller HK; Kihm U
    Vet Microbiol; 1992 Feb; 30(2-3):99-112. PubMed ID: 1313624
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improvement of the immune response to foot and mouth disease virus vaccine in calves by using Avridine as adjuvant.
    Sadir AM; Zamorano PI; Romera A; Wigdorovitz A; Smitsaart E; Marangunich L; Schiappacassi C; Borca MV
    Vet Immunol Immunopathol; 1999 Jul; 69(1):11-22. PubMed ID: 10490231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-affinity antibody induced by immunization with a synthetic peptide is associated with protection of cattle against foot-and-mouth disease.
    Steward MW; Stanley CM; Dimarchi R; Mulcahy G; Doel TR
    Immunology; 1991 Jan; 72(1):99-103. PubMed ID: 1847695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A synthetic peptide containing the consensus sequence of the G-H loop region of foot-and-mouth disease virus type-O VP1 and a promiscuous T-helper epitope induces peptide-specific antibodies but fails to protect cattle against viral challenge.
    Rodriguez LL; Barrera J; Kramer E; Lubroth J; Brown F; Golde WT
    Vaccine; 2003 Sep; 21(25-26):3751-6. PubMed ID: 12922108
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Production and application of recombinant antibodies to foot-and-mouth disease virus non-structural protein 3ABC.
    Foord AJ; Muller JD; Yu M; Wang LF; Heine HG
    J Immunol Methods; 2007 Apr; 321(1-2):142-51. PubMed ID: 17328909
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heterogeneity in the Antibody Response to Foot-and-Mouth Disease Primo-vaccinated Calves.
    Di Giacomo S; Brito BP; Perez AM; Bucafusco D; Pega J; Rodríguez L; Borca MV; Pérez-Filgueira M
    Transbound Emerg Dis; 2015 Jun; 62(3):280-7. PubMed ID: 23895140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potency assessment of foot-and-mouth disease vaccines in cattle by means of antibody assays.
    Amadori M; Archetti IL; Tollis M; Buonavoglia C; Panina GF
    Biologicals; 1991 Jul; 19(3):191-6. PubMed ID: 1659429
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Large-scale use of liquid-phase blocking sandwich ELISA for the evaluation of protective immunity against aphthovirus in cattle vaccinated with oil-adjuvanted vaccines in Argentina.
    Periolo OH; Seki C; Grigera PR; Robiolo B; Fernández G; Maradei E; D'Aloia R; La Torre JL
    Vaccine; 1993; 11(7):754-60. PubMed ID: 8393607
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A complex-trapping-blocking (CTB) ELISA, using monoclonal antibodies and detecting specifically antibodies directed against foot-and-mouth disease types A, O and C. II. Application.
    van Maanen C
    Vet Microbiol; 1990 Aug; 24(2):179-91. PubMed ID: 2173249
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protective immune response to liposome adjuvanted high potency foot-and-mouth disease vaccine in Indian cattle.
    Saravanan P; Sreenivasa BP; Selvan RP; Basagoudanavar SH; Hosamani M; Reddy ND; Nathanielsz J; Derozier C; Venkataramanan R
    Vaccine; 2015 Jan; 33(5):670-7. PubMed ID: 25528522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Application of monoclonal antibodies to quality control of foot-and-mouth disease vaccines.
    Alonso A; Darsie GC; Teixeira AC; Reis JL; Mesquita JA
    Vaccine; 1994 Jun; 12(8):682-6. PubMed ID: 8091844
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.